![]() Soligenix Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases. | ![]() OxThera OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate. | ||
Founding Date | Founding Date 2020 | Founding Date 1987 | Founding Date N/A |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Austin, US HQ Ames, US | Locations Princeton, US HQ | Locations Stockholm, SE HQ Knoxville, US |
Employees | Employees 333% increase | Employees 1422% decrease | Employees 7 |
Valuation ($) | Valuation ($) 35.5 m | Valuation ($) 8.7 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $2.1m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) kr11m (FY, 2015) |
Net income | Net income ($34m) (FY, 2023) | Net income ($11.1m) (FY, 2025) | Net income (kr37.8m) (FY, 2015) |

Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases.
View company
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
View company